bestselling author, Johns Hopkins University
Marty Makary
bestselling author | Johns Hopkins University
About Marty
Martin Adel Makary is a British-American surgeon, professor, and bestselling author affiliated with Johns Hopkins University. He has practiced surgical oncology and gastrointestinal laparoscopic surgery at Johns Hopkins Hospital and held the position of Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine. Makary served as the 27th Food and Drug Administration commissioner from 2025 to 2026. Throughout his career, he has pioneered advanced laparoscopic procedures, including the first laparoscopic Whipple and Frey’s procedures at Johns Hopkins. He also led the development of the Surgery Checklist in collaboration with the World Health Organization. Makary has held multiple leadership roles at Johns Hopkins, such as Credentials Chair, Director of Quality and Safety for Surgery, and clinical lead for the Sibley Innovation Hub. He has published extensively on surgical safety, hospital quality, and healthcare reform topics. His books, including Unaccountable, The Price We Pay, Mama Maggie, and Blind Spots, focus on healthcare system improvements, the evaluation of medical practices, and humanitarian narratives. A member of the National Academy of Medicine since 2018, Makary has been a controversial figure, notably for research suggesting medical errors are the third leading cause of death in the United States. During the COVID-19 pandemic, he supported universal masking and adult vaccination but opposed broad vaccine mandates, certain restrictions, and booster shots for younger populations. His tenure as FDA commissioner focused on modernizing regulatory processes and implementing AI-assisted review tools before resigning in 2026 following policy decisions regarding e-cigarettes.
Summary based on Wikipedia, available under CC BY-SA.
Latest interviews
Every podcast episode Marty Makary has appeared on, newest first.
The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 Minutes
May 15, 2026 | FDA's CDER Chief Høeg Expected to Exit; Tecentriq Wins Bladder Cancer Approval
May 17, 2026
Health:Further
190 - Marty Makary Resigns, AI Bubble Concerns Grow, and Healthcare Keeps California Afloat
May 16, 2026
Get Free with Kristi Leigh
Malone Unleashed: The Real Reason Makary was "Resigned" & Hantavirus Psyop
May 14, 2026
the Profane Argument, atheist podcast
Ep#481: Get your Trump Phone yet?
May 13, 2026
The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 Minutes
May 12, 2026 | FDA Commissioner Makary Resigns; BMS-Hengrui $15.2B 13-Asset Alliance
May 13, 2026
The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 Minutes
May 08, 2026 | Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August
May 9, 2026
American Dish
FDA's food agenda, one year in with FDA Commissioner Marty Makary
Mar 6, 2026
Podcast Notes Playlist: Nutrition
Supercharging a New FDA: Marty Makary on Science, Power & Patients
Jan 19, 2026
Speaks about
Topics hosts book Marty to cover, drawn from the episodes where they appear.
Appeared On
Browse the full historical catalogue of shows that have previously hosted Marty.
Relentless Health Value
4 episodes
Shows
4
The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 Minutes
3 episodes
Shows
3
Parenting Great Kids with Dr. Meg Meeker
3 episodes
Shows
3
Full Measure After Hours
2 episodes
Shows
2
Mission Daily
2 episodes
Shows
2
Health:Further
1 episode
Shows
1
Get Free with Kristi Leigh
1 episode
Shows
1
the Profane Argument, atheist podcast
1 episode
Shows
1
Guests who appear alongside
Guests who share the same shows as Marty. Worth a look if you are building a panel or pitching the same circuit.
Browse related cuts
This profile is auto-generated from publicly available podcast episode metadata. Is this profile about you? Request removal or email privacy@pitchcentric.com.
FAQs
Every question we get asked before
someone starts their trial.
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
What is the difference between Founder Solo and Founder Pro?
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
How do agency tiers work?
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
What is a talent profile?
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Can I switch plans later?
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Do you offer a free trial?
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
What happens if I cancel?
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Is the 20% annual discount automatic?
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
What if I have more than 50 profiles or 20 clients?
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.